Charles River Laboratories CRL Deferred Compensation Arrangement With Individual Compensation Expense
Deferred Compensation Arrangement With Individual Compensation Expense at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense.
The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's deferred compensation arrangement with individual compensation expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's deferred compensation arrangement with individual compensation expense?
- Charles River Laboratories (CRL) reported deferred compensation arrangement with individual compensation expense of $850K in Q4 2025.
- How has Charles River Laboratories's deferred compensation arrangement with individual compensation expense changed year-over-year?
- Charles River Laboratories's deferred compensation arrangement with individual compensation expense increased by 13.3% year-over-year, from $750K to $850K.
- What is the long-term trend for Charles River Laboratories's deferred compensation arrangement with individual compensation expense?
- Over 2 years (2023 to 2025), Charles River Laboratories's deferred compensation arrangement with individual compensation expense has grown at a 10.2% compound annual growth rate (CAGR), from $2.8M to $3.4M.
- What does deferred compensation arrangement with individual compensation expense mean?
- The total expense recognized during the period related to deferred compensation arrangements for specific individuals, typically executives. This includes accruals for future payments that are contingent upon continued service or performance.